BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6662552)

  • 21. Androgen and glucocorticoid regulation of androgen receptor cDNA expression.
    Burnstein KL; Maiorino CA; Dai JL; Cameron DJ
    Mol Cell Endocrinol; 1995 Dec; 115(2):177-86. PubMed ID: 8824893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-affinity androgen binding and androgenic regulation of alpha 1(I)-procollagen and transforming growth factor-beta steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells.
    Benz DJ; Haussler MR; Thomas MA; Speelman B; Komm BS
    Endocrinology; 1991 Jun; 128(6):2723-30. PubMed ID: 2036957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of growth and induction of apoptosis by androgens of a variant of LNCaP cell line.
    Joly-Pharaboz MO; Ruffion A; Roch A; Michel-Calemard L; André J; Chantepie J; Nicolas B; Panaye G
    J Steroid Biochem Mol Biol; 2000; 73(5):237-49. PubMed ID: 11070352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
    Poulin R; Baker D; Poirier D; Labrie F
    Breast Cancer Res Treat; 1989 Mar; 13(2):161-72. PubMed ID: 2525057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory and stimulatory effects of glucocorticoid on androgen-induced growth of murine Shionogi carcinoma 115 in vivo and in cell culture.
    Hiraoka D; Nakamura N; Nishizawa Y; Uchida N; Noguchi S; Matsumoto K; Sato B
    Cancer Res; 1987 Dec; 47(24 Pt 1):6560-4. PubMed ID: 3677094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line.
    Hofbauer LC; Hicok KC; Khosla S
    J Cell Biochem; 1998 Oct; 71(1):96-108. PubMed ID: 9736458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgens induce divergent proliferative responses in human breast cancer cell lines.
    Birrell SN; Bentel JM; Hickey TE; Ricciardelli C; Weger MA; Horsfall DJ; Tilley WD
    J Steroid Biochem Mol Biol; 1995 May; 52(5):459-67. PubMed ID: 7748811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen receptor-mediated growth and epidermal growth factor receptor induction in the human prostate cell line LNCaP.
    Schuurmans AL; Bolt J; Mulder E
    Urol Int; 1989; 44(2):71-6. PubMed ID: 2728128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steroid-regulated growth of DDT1MF-2 cells is profoundly influenced by culture conditions.
    Lamb DJ; Ray M
    In Vitro Cell Dev Biol Anim; 1995 Dec; 31(11):871-5. PubMed ID: 8826092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transformation of the 10S androgen receptor in a hamster ductus deferens tumor cell line.
    Colvard DS; Wilson EM
    Endocrinology; 1987 Sep; 121(3):931-40. PubMed ID: 3622384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation.
    Léotoing L; Manin M; Monté D; Baron S; Communal Y; Lours C; Veyssière G; Morel L; Beaudoin C
    J Mol Endocrinol; 2007 Aug; 39(2):151-62. PubMed ID: 17693613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
    Brass AL; Barnard J; Patai BL; Salvi D; Rukstalis DB
    Cancer Res; 1995 Jul; 55(14):3197-203. PubMed ID: 7606741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance of androgen responsiveness by glucocorticoids in Shionogi mammary carcinoma cells in culture.
    Labrie F; Veilleux R; Fournier A
    J Natl Cancer Inst; 1988 Aug; 80(12):966-70. PubMed ID: 3398072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture.
    Noguchi S; Nishizawa Y; Nakamura N; Uchida N; Yamaguchi K; Sato B; Kitamura Y; Matsumoto K
    Cancer Res; 1987 Jan; 47(1):263-8. PubMed ID: 3791211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of glucocorticoid sensitive secretory proteins from human melanoma cells.
    Di Sorbo DM
    In Vitro Cell Dev Biol; 1989 Jun; 25(6):557-63. PubMed ID: 2737997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen down-regulation of androgen receptors in cultured human mammary cancer cells (MCF-7).
    Stover EP; Krishnan AV; Feldman D
    Endocrinology; 1987 Jun; 120(6):2597-603. PubMed ID: 3569146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro growth inhibition of human malignant melanoma cells by glucocorticoids.
    DiSorbo DM; McNulty B; Nathanson L
    Cancer Res; 1983 Jun; 43(6):2664-7. PubMed ID: 6850583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgens and the thymus.
    Pearce P; Khalid BA; Funder JW
    Endocrinology; 1981 Oct; 109(4):1073-7. PubMed ID: 7285862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of antibody against basic fibroblast growth factor on androgen- or glucocorticoid-induced growth of Shionogi carcinoma 115 cells in serum-free culture.
    Lu J; Nishizawa Y; Tanaka A; Nonomura N; Yamanishi H; Uchida N; Sato B; Matsumoto K
    Cancer Res; 1989 Sep; 49(18):4963-7. PubMed ID: 2766270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of glucocorticoids on the growth of human fibrosarcoma cell line HT-1080.
    Walker MJ; Lim C; Das Gupta TK; Beattie CW
    Cancer Res; 1986 Oct; 46(10):4927-32. PubMed ID: 3756854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.